Atlas Trials

Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis

Clinical trial NCT03118492 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03118492
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Secondary Myelofibrosis
Start date
2017-05-24
Primary completion
2027-04-29
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.